Vanderbilt University Medical Center

  • ResearchMatch Logo
    -
    Vanderbilt University Medical Center
    The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is excited to present one of its newest resources, "Ensuring Language Access and Linguistic Competence: A Guide for Researchers" at the National ResearchMatch Liaison Team Call 2022 Series. Join us Wednesday, July 27th at 2pm (ET) for this virtual event. Persons with limited English proficiency (LEP), those
  • YIN and CLIC homepage collage
    -
    Vanderbilt University Medical Center

    MyCap is a mobile application integrated with REDCap that can be easily configured without programming to collect ongoing participant information and patient-reported outcomes directly from study participants. Study teams can use MyCap to support participant engagement and retention on studies ranging from complex remote/no touch trials, studies using daily medication diaries, or studies seeking

  • YIN and CLIC homepage collage
    Vanderbilt University Medical Center

    In this webinar, the Vanderbilt Recruitment Innovation Center (RIC) Recruitment Materials Team will share their new Recruitment and Retention Materials Content + Design Toolkit. This toolkit is a resource for research teams to utilize to create participant recruitment and retention materials, as well as materials for clinician awareness/study referrals. It includes: 1) guidelines, recommendations

  • As recently published, the IREx platform helps operationalize the single IRB (sIRB) mandate (doi:10.1017/cts.2022.376). More than 30 sIRBs are using IREx for over 450 studies with 2600 reliances, and new sIRBs use IREx each year given its utility for lead study teams and coordinating centers. IREx standardizes the sIRB process, automates communications, captures documentation from sites, and

  • Members of the University of Rochester Clinical and Translational Science Institute and Vanderbilt Institute for Clinical and Translational Research teamed up to create an external module for REDCap that makes it easier for anyone to create research surveys that are accessible for use with Deaf and DeafBlind people. The effort, which was spearheaded by Deaf researchers in the National Center for
  • Vanderbilt University Medical Center has competed successfully for a third five-year renewal of its Clinical and Translational Science (UL1) Award by the National Center for Advancing Translational Sciences. Initially funded in 2007, the renewal will provide more than $73 million for another five years to support the Vanderbilt Institute for Clinical and Translational Research (VICTR) and its

  • Consuelo Wilkins, MD, MSCI, Senior Vice President and Senior Associate Dean for Health Equity and Inclusive Excellence and professor of Medicine at Vanderbilt University Medical Center, has been elected to membership in the American Society for Clinical Investigation. Internationally recognized for her pioneering efforts to effectively engage historically marginalized communities in the design and
  • Vanderbilt University Medical Center
    -
    Vanderbilt University Medical Center
    The CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
  • TIN Logo
    -
    Vanderbilt University Medical Center

    Stanford Medicine’s Research Participation services has developed the Participant Engagement Platform (PEP) as a way of offering and managing “honest broker” outreach, such as Direct Email and Epic MyChart. The Research Participation team (honest broker) sends the study invitation to potential participants (identified via EHR cohort search) on behalf of the study team. Only when a potential

  • TIN Logo
    -
    Vanderbilt University Medical Center

    This presentation will help answer the question “Should you go online” and other things to consider when deciding if social media will be an option to add to your recruitment plan.

  • TIN Logo
    -
    Vanderbilt University Medical Center

    By the end of this presentation, viewers will be able to: 1. Define team science and differentiate team science research from more traditional forms 2. Identify how team science is promoted by the NIH 3. Explain the benefits and shortcomings of teams science research 4. Describe the risks associated with team science models and how to overcome them 5. Describe real-world examples of how team

  • TIN Logo
    -
    Vanderbilt University Medical Center

    Clinical research must be modernized. There are increasing demands to have more rapid innovation in order to develop novel treatments more quickly and cost effectively. The challenges that COVID add to the landscape of clinical trials also brings potential for new pathways of clinical trial innovation. Join this discussion to hear about the potential factors driving the decision to use an

  • TIN Logo
    -
    Vanderbilt University Medical Center

    We will provide an overview of the project aims and progress so far in building this collaborative set of tools to collect, analyze, share and act on participant feedback. We will describe how the project integrates with into local participant-centered initiatives at collaborating sites.

  • TIN Logo
    -
    Vanderbilt University Medical Center

    This webinar will provide an overview of the STELLAR prototype– an interactive web-based system to assess the learning needs of the clinical and translational research workforce, a Self-career Training, Education, Life-long Learning Advancement Resource.

  • TIN Logo
    -
    Vanderbilt University Medical Center

    Researchers planning COVID-19 trials with the Trial Innovation Network (TIN) can leverage the N3C to inform their research hypotheses. N3C focuses on aligning its infrastructure so that it can generate efficient and minimally biased results. Part of that infrastructure includes the curation of value sets and phenotype variables relevant to COVID-19, such as ventilator support, ICU use, and

  • TIN Logo
    -
    Vanderbilt University Medical Center

    Learn more about obtaining patient-center feedback from underrepresented groups to enhance your research project even in the times of COVID. The CES Team will highlight it’s transition to the use of Zoom technology, how to address issues of tech-equity and literacy, and share lessons learned for effectively facilitating group dialogue in a virtual forum.

  • TIN Logo
    -
    Vanderbilt University Medical Center

    This webinar presents scholarly research conducted by the Tufts Center for the Study of Drug Development, Tufts University School of Medicine examining trends in protocol design practice and their impact on clinical trial performance and quality. In particular, the webinar will explore innovative approaches being used to leverage patient and study volunteer input and experience to modify protocol

  • Vasculitis Clinical Research Consortium

    Vasculitis refers to a group of rare diseases that involve inflammation of blood vessels, which disrupts blood flow and often causes damage to the body’s organs. The cause of most forms of vasculitis remains unknown, and treatments involve the use of strong medications that can have serious side effects. The Vasculitis Clinical Research Consortium (VCRC) is an international, multicenter clinical

  • Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

    Eosinophilic esophagitis, eosinophilic gastritis, eosinophilic gastroenteritis, and eosinophilic colitis are disorders in which a type of immune cell (called eosinophils) builds up in the digestive tract, causing gastrointestinal tissue damage. These disorders are painful, lifelong, and make it hard or impossible for people to eat many or all foods. The Consortium of Eosinophilic Gastrointestinal

  • Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (CPIC)

    The Congenital and Perinatal Infections Consortium (CPIC) is focused on reducing the morbidity and mortality of rare viral infections such as congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal viral sepsis caused by enteroviruses (EVs) and the related human parechoviruses (HPeVs). These infections have been grouped together because of their

  • Trial Innovation Network Logo
    -
    Vanderbilt University Medical Center

    Implementing your research project within an Electronic Health Record (EHR) system is an exciting but complex endeavor that requires specialized tools and approaches. This talk will unpack what dedicated teams of informaticians have pioneered over the past decade. It will help the researcher understand a path forward for their research protocols. The talk addresses key differences between

  • Trial Innovation Network Logo
    -
    Vanderbilt University Medical Center

    The NIA staff will discuss some of the limitations with inclusion of diverse populations observed in clinical research and trials, the role federal science policy is playing in remedying the limitations and promoting more broad and consistent inclusion of communities of color in developing new strategies implemented to enhance inclusion among older persons of color. The NIA team will provide an

  • Vanderbilt University Medical Center

    At the Vanderbilt Institute for Clinical and Translational Research (VICTR), led by Gordon Bernard, MD, and Consuelo Wilkins, MD, MSCI, we are leading local and national efforts to address urgent and emerging COVID-19 research needs. Nationally, the global pandemic has showcased the ability of the CTSA Hubs to adapt with speed and precision, particularly in the area of informatic and data

  • University Of Massachusetts Med Sch Worcester
    University Of Alabama At Birmingham
    Vanderbilt University Medical Center

    INTRODUCTION Under-representation in health-related research is one of a multitude of factors that contribute to health disparities experienced by African American and Latinx communities, and has been brought to the forefront in the context of the COVID-19 pandemic. Barriers to research participation stem from historical social injustices, are multi-faceted and include factors specific to the

  • Vanderbilt University Medical Center

    Trials Today, a tool from ResearchMatch and Vanderbilt University, offers prospective research participants a quick way to search the thousands of studies available on ClinicalTrials.gov. By answering a few short questions, Trials Today can help find a list of studies that may interest a prospective participant. The Spanish version of Trials Today is now also live.

  • Vanderbilt University Medical Center
    This course aims to teach people how to enhance the recruitment of racial and ethnic minorities in clinical trials. Key topics include the importance of diversity in clinical trials, barriers and facilitators to participation in clinical research, community engagement, effective communication, educating about clinical trials, provider outreach, effective prescreening and enrollment, person
  • Vanderbilt University Medical Center
    The Meharry-Vanderbilt Community Engaged Research Core (CERC) at the Vanderbilt Institute for Clinical and Translational Research (VICTR) works to bring together academic researchers and community members to improve community health and healthcare through community-engaged research. The Community Engagement (CE) Studio is one of the unique services developed by CERC to further this mission. The CE
  • Trial Innovation Network Logo
    -
    Vanderbilt University Medical Center

    This webinar will provide an updated overview of Trials Today – an online tool that helps potential participants find studies that are of interest to them and their health condition. Trials Today is a quick and easy way to search the thousands of studies in ClinicalTrials.gov that are recruiting participants.

  • Trial Innovation Network Logo
    -
    Vanderbilt University Medical Center

    A collaborative research model was developed and tested to enable regional healthcare systems to join multisite clinical trials emanating from the Clinical and Translational Science Award(CTSA) Trial Innovation Network (TIN) by the Institute of Translational Health Sciences at the University of Washington and the Northwest Participant and Clinical Interactions(NW PCI) Network. The NW PCI is a